Universal Medical’s Subsidiary Plans Second-Tranche Bond Issue of up to RMB1.00 Billion on SSE

Bulletin Express17:06

Genertec Universal Medical Group Company Limited (Universal Medical) disclosed that its wholly-owned leasing arm, China Universal Leasing Co., Ltd., has initiated the second tranche (T2) of a multi-phase onshore bond programme approved by the China Securities Regulatory Commission.

Key parameters • Programme size: RMB8.00 billion, with RMB3.40 billion remaining prior to this tranche. • Tranche 2 size: not exceeding RMB1.00 billion. • Tenor: basic five-year term; issuer call and coupon reset options at the end of years three and four; investor sell-back option at the same junctures. • Issuance method: offline bookbuild and placement to qualified institutional investors under the Administrative Measures for the Issuance and Trading of Corporate Bonds. • Listing venue: Shanghai Stock Exchange. • Par/issue price: RMB100 per bond. • Credit rating: AAA for the issuer. • Expected book-building date: 23 April 2026.

The CSRC authorisation requires completion of the overall RMB8.00 billion programme within 24 months of approval. Universal Medical will release further announcements on the progress of Tranche 2 and any subsequent issuances as necessary.

The company emphasized that PRC-filed offering documents relate solely to China Universal Leasing and do not represent the full operational profile of Universal Medical or its other subsidiaries.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1113750455?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-22 17:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1113750455","market":"us","top_or_hot":-1,"title":"Universal Medical’s Subsidiary Plans Second-Tranche Bond Issue of up to RMB1.00 Billion on SSE","media":"Bulletin Express","content":"<p>Genertec Universal Medical Group Company Limited (Universal Medical) disclosed that its wholly-owned leasing arm, China Universal Leasing Co., Ltd., has initiated the second tranche (T2) of a multi-phase onshore bond programme approved by the China Securities Regulatory Commission.</p>\n<p>Key parameters  \n• Programme size: RMB8.00 billion, with RMB3.40 billion remaining prior to this tranche.  \n• Tranche 2 size: not exceeding RMB1.00 billion.  \n• Tenor: basic five-year term; issuer call and coupon reset options at the end of years three and four; investor sell-back option at the same junctures.  \n• Issuance method: offline bookbuild and placement to qualified institutional investors under the Administrative Measures for the Issuance and Trading of Corporate Bonds.  \n• Listing venue: Shanghai Stock Exchange.  \n• Par/issue price: RMB100 per bond.  \n• Credit rating: AAA for the issuer.  \n• Expected book-building date: 23 April 2026.</p>\n<p>The CSRC authorisation requires completion of the overall RMB8.00 billion programme within 24 months of approval. Universal Medical will release further announcements on the progress of Tranche 2 and any subsequent issuances as necessary.</p>\n<p>The company emphasized that PRC-filed offering documents relate solely to China Universal Leasing and do not represent the full operational profile of Universal Medical or its other subsidiaries.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Universal Medical’s Subsidiary Plans Second-Tranche Bond Issue of up to RMB1.00 Billion on SSE</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUniversal Medical’s Subsidiary Plans Second-Tranche Bond Issue of up to RMB1.00 Billion on SSE\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-22 17:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Genertec Universal Medical Group Company Limited (Universal Medical) disclosed that its wholly-owned leasing arm, China Universal Leasing Co., Ltd., has initiated the second tranche (T2) of a multi-phase onshore bond programme approved by the China Securities Regulatory Commission.</p>\n<p>Key parameters  \n• Programme size: RMB8.00 billion, with RMB3.40 billion remaining prior to this tranche.  \n• Tranche 2 size: not exceeding RMB1.00 billion.  \n• Tenor: basic five-year term; issuer call and coupon reset options at the end of years three and four; investor sell-back option at the same junctures.  \n• Issuance method: offline bookbuild and placement to qualified institutional investors under the Administrative Measures for the Issuance and Trading of Corporate Bonds.  \n• Listing venue: Shanghai Stock Exchange.  \n• Par/issue price: RMB100 per bond.  \n• Credit rating: AAA for the issuer.  \n• Expected book-building date: 23 April 2026.</p>\n<p>The CSRC authorisation requires completion of the overall RMB8.00 billion programme within 24 months of approval. Universal Medical will release further announcements on the progress of Tranche 2 and any subsequent issuances as necessary.</p>\n<p>The company emphasized that PRC-filed offering documents relate solely to China Universal Leasing and do not represent the full operational profile of Universal Medical or its other subsidiaries.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02666","symbol_name":"环球医疗","start_time":0,"source_url":"","article_id":"1113750455","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1113750455","pubTimestamp":1776848762,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Genertec Universal Medical Group Company Limited (Universal Medical) disclosed that its wholly-owned leasing arm, China Universal Leasing Co., Ltd., has initiated the second tranche (T2) of a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02666":"环球医疗"},"translate_title":"环球医疗子公司拟在上交所发行不超过10亿元人民币的第二期债券","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02666":1},"content_text":"Genertec Universal Medical Group Company Limited (Universal Medical) disclosed that its wholly-owned leasing arm, China Universal Leasing Co., Ltd., has initiated the second tranche (T2) of a multi-phase onshore bond programme approved by the China Securities Regulatory Commission.\nKey parameters  \n• Programme size: RMB8.00 billion, with RMB3.40 billion remaining prior to this tranche.  \n• Tranche 2 size: not exceeding RMB1.00 billion.  \n• Tenor: basic five-year term; issuer call and coupon reset options at the end of years three and four; investor sell-back option at the same junctures.  \n• Issuance method: offline bookbuild and placement to qualified institutional investors under the Administrative Measures for the Issuance and Trading of Corporate Bonds.  \n• Listing venue: Shanghai Stock Exchange.  \n• Par/issue price: RMB100 per bond.  \n• Credit rating: AAA for the issuer.  \n• Expected book-building date: 23 April 2026.\nThe CSRC authorisation requires completion of the overall RMB8.00 billion programme within 24 months of approval. Universal Medical will release further announcements on the progress of Tranche 2 and any subsequent issuances as necessary.\nThe company emphasized that PRC-filed offering documents relate solely to China Universal Leasing and do not represent the full operational profile of Universal Medical or its other subsidiaries.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1113750455","isCrawlerRequest":true}